Page 285 - Vitamin D and Cancer

272 R. Okamoto et al.

53. Koeffler HP, Hirji K, Itri L (Dec, 1985) 1,25-Dihydroxyvitamin D3: in vivo and in vitro
effects on human preleukemic and leukemic cells. Cancer Treat Rep 69(12):1399–407
54. Tasaka T, Tokuda M, Taoka T, Itano T, Matsui H, Etoh S, Nishio H, Miyamoto O, Irino S,
Hatase O (Jan, 1991) Mechanism of transient increase in intracellular concentration of free
calcium ions in HL-60 cell differentiation induced by vitamin D3 and phorbol ester. Biochem
Int 23(l):137–43
55. Nagler A, Merchav S, Fabian I, Tatarsky I, Weisman Y, Hochberg Z (Nov, 1987) Myeloid
progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail
to respond to 1,25(OH)2D3. Br J Haematol 67(3):267–71
56. Koeffler HP, Bishop JE, Reichel H, Singer F, Nagler A, Tobler A, Walka M, Norman AW
(Mar 26, 1990) Lymphocyte cell lines from vitamin D-dependent rickets type II show func-
tional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor. Mol Cell Endocrinol
70(1):1–11
57. Rots NY, Iavarone A, Bromleigh Y, Freedman LP (Apr 15, 1999) Induced differentiation of
U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by
a transient proliferative burst and an increase in cyclin expression. Blood 93(8):2721–9
58. Campbell MJ, Drayson MT, Durham J, Wallington L, Siu-Caldera ML, Reddy GS, Brown G
(Mar 25, 1999) Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal
expansion, maturation and apoptosis during HL-60 cell differentiation. Mol Cell Endocrinol
149(1–2):169–83
59. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (Jan 15, 1996) Transcriptional
activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the
myelomonocytic cell line U937. Genes Dev 10(2):142–53
60. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A (Mar, 1995)
Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/
SD11 in differentiating human leukemic cells. J Clin Invest 95(3):973–9
61. Wang QM, Jones JB, Studzinski GP (Jan 15) Cyclin-dependent kinase inhibitor p27 as a
mediator of the G1 -S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
Cancer Res 56(2):264–7
62. Xu HM, Tepper CG, Jones JB, Fernandez CE, Studzinski GP (Dec, 1993)
1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the
expression of the bcl-2 gene. Exp Cell Res 209(2):367–74
63. Wu YL, Jiang XR, Lillington DM, Allen PD, Newland AC, Kelsey SM (Feb 15, 1998)
1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-
induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res 58(4):633–40
64. Dalla-Favera R, Wong-Staal F, Gallo RC (Sep 2, 1982) Onc gene amplification in promyelo-
cytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature
299(5878):61–3
65. Obeid LM, Okazaki T, Karolak LA, Hannun YA (Feb 5, 1990) Transcriptional regulation of
protein kinase C by 1,25-dihydroxyvitarnin D3 in HL-60 cells. J Biol Chem 265(4):2370–4
66. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn
AJ (Dec 1–7, 1983) Regulation of myc gene expression in HL-60 leukaemia cells by a vita-
min D metabolite. Nature 306(5942):492–4
67. Simpson RU, Hsu T, Begley DA, Mitchell BS, Alizadeh BN (Mar 25, 1987) Transcriptional
regulation of the c-myc protooncogene by 1,25-dihydroxyvitamin D3 in HL-60 promyelo-
cytic leukemia cells. J Biol Chem 262(9):4104–8
68. Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP (Jul, 1989)
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little
effect on either intestinal calcium absorption or bone mobilization. Blood 74(1):82–93
69. Rowley PT, Farley B, Giuliano R, LaBella S, Leary JF (1992) Induction of the fms proto-
oncogene product in HL-60 cells by vitamin D: a flow cytometric analysis. Leuk Res
16(4):403–10
70. Pan Q, Martell RE, O’Connell TD, Simpson RU (Oct, 1996) 1,25-Dihydroxyvitamin D3-regulated
binding of nuclear proteins to a c-myc intron element. Endocrinology 137(10):4154–60